We evaluate DeepCode on the PaperBench benchmark (released by OpenAI), a rigorous testbed requiring AI agents to independently reproduce 20 ICML 2024 papers from scratch. The benchmark comprises 8,316 ...

Vibe coding turns software development into a conversation. You focus on the idea, and the AI model handles most of the implementation. Barbara is a tech writer specializing in AI and emerging ...

Developers are navigating confusing gaps between expectation and reality. So are the rest of us. Depending who you ask, AI-powered coding is either giving software developers an unprecedented ...

MotionEdit is a novel dataset and benchmark for motion-centric image editing. We also propose MotionNFT (Motion-guided Negative-aware FineTuning), a post-training framework with motion alignment ...

The hype surrounding AI in software development is undeniable. We are witnessing a paradigm shift, where "vibe coding" — expressing intent in natural language and leveraging AI large language models ...

“We do one book after state testing, and we did ‘The Great Gatsby.’ … A lot of kids had not read a novel in class before.” — Laura Henry, 10th-grade English teacher near Houston “My son in 9th grade ...

The 300-person startup hopes bringing designers aboard will give it an edge in an increasingly competitive AI software market. Cursor, the wildly popular AI coding startup, is launching a new feature ...

Artificial intelligence (AI) agents are a breeze to create using Microsoft Copilot Studio, and almost just as easy to manipulate into divulging sensitive corporate data. Despite broad security ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

When OpenAI CEO Sam Altman made the dramatic call for a “code red” last week to beat back a rising threat from Google, he put a notable priority at the top of his list of fixes. The world’s most ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Building a golden path to AI Your team members may not be straight-up vibe coding, but they’re almost certainly using AI tools that management hasn’t signed off on, which is like shadow IT on steroids ...